CML Euro Score TKI Response Prediction

Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib

Each component has a specific meaning:

  • Basophil percentage — The basophil percentage recorded for the scenario being assessed.
  • Spleen size — The spleen size recorded for the scenario being assessed.

Note: Interpret the cml euro score result against the thresholds and context described above.

How to Use

Enter the basophil percentage, spleen size for the scenario you are assessing. Apply the EUTOS (European Treatment and Outcome Study) score using basophil percentage and spleen size to identify CML patients unlikely to achieve complete cytogenetic remission with imatinib. Use the cml euro score result to inform your calculation.

Frequently Asked Questions